Contents

Current Pharmaceutical Design, Volume 9 - Number 3

Preface

, 9(3): ii

med.Dorothea Stahl


DOI: 10.2174/13816128103090300ii




Natural Killer T Cells as Targets for Therapeutic Intervention in Autoimmune Diseases

, 9(3): 201 - 220

M. T. Wilson and L. Van. Kaer


DOI: 10.2174/1381612033392080




Dendritic Cell Homeostasis in the Regulation of Self-Reactivity

, 9(3): 221 - 231

Burkhard Ludewig, Philippe Krebs, Tobias Junt and Gennady Bocharov


DOI: 10.2174/1381612033392044




Modulation of T Cell Immunity by TCR / pMHC Dwell Time and Activating / Inhibitory Receptor Pairs on the Antigen-Presenting Cell

, 9(3): 233 - 244

Alexis M. Kalergis


DOI: 10.2174/1381612033392062




Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy

, 9(3): 245 - 256

Orhan Aktas and Frauke Zipp


DOI: 10.2174/1381612033392152




Macrophages and the Regulation of Self-Reactive T Cells

, 9(3): 257 - 264

David H. Munn and Andrew L. Mellor


DOI: 10.2174/1381612033392026




Autoimmune Lymphoproliferative Syndrome (ALPS)

, 9(3): 265 - 278

Jack J.H. Bleesing


DOI: 10.2174/1381612033392107




Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support

, 9(3): 279 - 288

Yossi Cohen, Aaron Polliack and Arnon Nagler


DOI: 10.2174/1381612033392134




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science